360 related articles for article (PubMed ID: 3950467)
61. Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses.
Papiris SA; Vlachoyiannopoulos PG; Maniati MA; Karakostas KX; Constantopoulos SH; Moutsopoulos HH
Respiration; 1997; 64(1):81-5. PubMed ID: 9044481
[TBL] [Abstract][Full Text] [Related]
62. [Pulmonary inflammation in systemic sclerosis. An assessment by bronchoalveolar lavage].
Salaffi F; Subiaco S; Carotti M; Blasetti P; Cervini C
Recenti Prog Med; 1994 Oct; 85(10):475-80. PubMed ID: 7809460
[TBL] [Abstract][Full Text] [Related]
63. Structural features of interstitial lung disease in systemic sclerosis.
Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314
[TBL] [Abstract][Full Text] [Related]
64. BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis.
Scheja A; Larsen K; Todorova L; Tufvesson E; Wildt M; Akesson A; Hansson L; Ellis S; Westergren Thorsson G
Eur Respir J; 2007 Mar; 29(3):446-52. PubMed ID: 17107986
[TBL] [Abstract][Full Text] [Related]
65. Recent advances in pulmonary fibrosis: implications for scleroderma.
Homer RJ; Herzog EL
Curr Opin Rheumatol; 2010 Nov; 22(6):683-9. PubMed ID: 20693906
[TBL] [Abstract][Full Text] [Related]
66. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
Harrison NK; Glanville AR; Strickland B; Haslam PL; Corrin B; Addis BJ; Lawrence R; Millar AB; Black CM; Turner-Warwick M
Respir Med; 1989 Sep; 83(5):403-14. PubMed ID: 2694236
[TBL] [Abstract][Full Text] [Related]
67. Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis.
Imokawa S; Sato A; Hayakawa H; Kotani M; Urano T; Takada A
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):631-6. PubMed ID: 9279250
[TBL] [Abstract][Full Text] [Related]
68. Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.
Southcott AM; Jones KP; Li D; Majumdar S; Cambrey AD; Pantelidis P; Black CM; Laurent GJ; Davies BH; Jeffery PK
Am J Respir Crit Care Med; 1995 May; 151(5):1604-12. PubMed ID: 7735620
[TBL] [Abstract][Full Text] [Related]
69. [Incidence of collagenoses in patients with lung fibrosis].
Liebetrau G; Mäder I; Treutler D; Wiesner B
Z Gesamte Inn Med; 1988 Feb; 43(3):65-7. PubMed ID: 3369218
[TBL] [Abstract][Full Text] [Related]
70. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis.
Beon M; Harley RA; Wessels A; Silver RM; Ludwicka-Bradley A
Clin Exp Rheumatol; 2004; 22(6):733-42. PubMed ID: 15638048
[TBL] [Abstract][Full Text] [Related]
71. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease.
Kumánovics G; Zibotics H; Juhász E; Komócsi A; Czirják L
Clin Exp Rheumatol; 2001; 19(5):551-9. PubMed ID: 11579714
[TBL] [Abstract][Full Text] [Related]
72. Pulmonary involvement in systemic sclerosis (scleroderma).
Steen VD; Owens GR; Fino GJ; Rodnan GP; Medsger TA
Arthritis Rheum; 1985 Jul; 28(7):759-67. PubMed ID: 4015723
[TBL] [Abstract][Full Text] [Related]
73. [Multifocal fibrosis (localized systemic sclerosis)].
Guseva NG
Klin Med (Mosk); 1992; 70(3-4):8-14. PubMed ID: 1507857
[No Abstract] [Full Text] [Related]
74. Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members.
Bitterman PB; Rennard SI; Keogh BA; Wewers MD; Adelberg S; Crystal RG
N Engl J Med; 1986 May; 314(21):1343-7. PubMed ID: 3702942
[TBL] [Abstract][Full Text] [Related]
75. Organizing diffuse alveolar damage associated with progressive systemic sclerosis.
Muir TE; Tazelaar HD; Colby TV; Myers JL
Mayo Clin Proc; 1997 Jul; 72(7):639-42. PubMed ID: 9212765
[TBL] [Abstract][Full Text] [Related]
76. Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis.
Schwartz DA; Helmers RA; Dayton CS; Merchant RK; Hunninghake GW
J Appl Physiol (1985); 1991 Nov; 71(5):1688-93. PubMed ID: 1761464
[TBL] [Abstract][Full Text] [Related]
77. Carcinoembryonic antigen in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis.
Takahashi H; Nukiwa T; Matsuoka R; Danbara T; Natori H; Arai T; Kira S
Jpn J Med; 1985 Aug; 24(3):236-43. PubMed ID: 4068359
[TBL] [Abstract][Full Text] [Related]
78. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis.
White B; Moore WC; Wigley FM; Xiao HQ; Wise RA
Ann Intern Med; 2000 Jun; 132(12):947-54. PubMed ID: 10858177
[TBL] [Abstract][Full Text] [Related]
79. Macrophage infiltration in the skin of patients with systemic sclerosis.
Ishikawa O; Ishikawa H
J Rheumatol; 1992 Aug; 19(8):1202-6. PubMed ID: 1404154
[TBL] [Abstract][Full Text] [Related]
80. [Electron microscopy and autoradiography study of bronchoalveolar lavage cells in nonspecific pneumonia].
Nepomniashchikh GI; Efremov VN; Tumanov VP; Nepomniashchikh LM
Biull Eksp Biol Med; 1986 Jan; 101(1):105-9. PubMed ID: 3942805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
